Swedish Orphan Biovitrum AB (publ)
BIOVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,356,698 | $94,864,176 | $98,952,405 | $105,024,521 |
| - Cash | $110,030 | $1,058,000 | $997,000 | $1,140,000 |
| + Debt | $1,439,075 | $12,813,000 | $14,021,000 | $16,735,000 |
| Enterprise Value | $11,685,743 | $106,619,176 | $111,976,405 | $120,619,521 |
| Revenue | $823,478 | $6,175,000 | $6,465,000 | $7,436,000 |
| % Growth | -86.7% | -4.5% | -13.1% | – |
| Gross Profit | -$133,858 | $4,749,000 | $4,876,000 | $5,836,000 |
| % Margin | -16.3% | 76.9% | 75.4% | 78.5% |
| EBITDA | $387,276 | $1,899,000 | $2,296,000 | $2,593,000 |
| % Margin | 47% | 30.8% | 35.5% | 34.9% |
| Net Income | -$306,581 | $636,000 | $875,000 | $1,397,000 |
| % Margin | -37.2% | 10.3% | 13.5% | 18.8% |
| EPS Diluted | -0.89 | 1.83 | 2.52 | 4.03 |
| % Growth | -148.6% | -27.4% | -37.5% | – |
| Operating Cash Flow | $194,962 | $1,448,000 | $2,295,000 | $1,797,000 |
| Capital Expenditures | -$847 | -$421,000 | -$11,000 | -$61,000 |
| Free Cash Flow | $194,115 | $1,027,000 | $2,284,000 | $1,736,000 |